Skip to main navigation Skip to search Skip to main content

Targeted Radioiodine Therapy of Neuroblastoma Tumors following Systemic Nonviral Delivery of the Sodium Iodide Symporter Gene

  • Kathrin Klutz
  • , Verena Russ
  • , Michael J. Willhauck
  • , Nathalie Wunderlich
  • , Christian Zach
  • , Franz Josef Gildehaus
  • , Burkhard Goeke
  • , Ernst Wagner
  • , Manfred Ogris (Corresponding author)
  • , Christine Spitzweg

Publications: Contribution to journalArticlePeer Reviewed

Original languageEnglish
Pages (from-to)6079-6086
Number of pages8
JournalClinical Cancer Research
Volume15
Issue number19
DOIs
Publication statusPublished - 1 Oct 2009
Externally publishedYes

Funding

Grants Sp 581/4-1, Sp 581/4-2 (DFG Forschergruppe FCR411 'Radionuklidtherapie') as well as SFB 824 (DFG Sonderforschungsbereich 824) from the Deutsche Forschungsgemeinschaft, Bonn, Germany, and by a grant from the Wilhelm-Sander-Stiftung (2008.037.1) to C. Spitzweg, as well as the DFG-funded Nanosystems initiative Munich and EG-funded Project GIANT to M. Cgris and E. Wagner.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Austrian Fields of Science 2012

  • 301207 Pharmaceutical chemistry

Keywords

  • MEDULLARY-THYROID CANCER
  • PROSTATE-CANCER
  • SODIUM/IODIDE SYMPORTER
  • IN-VIVO
  • DNA COMPLEXES
  • EXPRESSION
  • CELLS
  • NIS
  • OLIGOETHYLENIMINE
  • RADIOVIROTHERAPY

Fingerprint

Dive into the research topics of 'Targeted Radioiodine Therapy of Neuroblastoma Tumors following Systemic Nonviral Delivery of the Sodium Iodide Symporter Gene'. Together they form a unique fingerprint.

Cite this